CIK 0001425205
- Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753254381
- Phone
- +1 650-260-7120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 250,000 shares at $9.15 ($2,287,500)
- 4 Open-market buy Director bought 32,000 shares at $9.15 ($292,800)
- 4 Open-market buy Director bought 5,000,000 shares at $9.15 ($45,750,000)
- 4 Shares withheld for taxes Interim CEO & General Counsel gave up 6,530 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,577 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,577 shares (to pay taxes)
- 4 Shares withheld for taxes Interim CEO & General Counsel gave up 8,851 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,395 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,395 shares (to pay taxes)
- 4 Open-market buy Director bought 10,000 shares at $5.56 ($55,600)
- 4 Open-market buy Director bought 5,000,000 shares at $5.30 ($26,500,000)
- 4 Shares withheld for taxes Interim CEO & General Counsel gave up 8,851 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,395 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,395 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 18 · 352 filings